Masimo Corporation (MASI)
Pretax margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | -305,300 | 88,100 | 193,400 | 274,439 | 263,702 |
| Revenue | US$ in thousands | 2,039,900 | 2,053,900 | 2,073,900 | 1,239,150 | 1,143,740 |
| Pretax margin | -14.97% | 4.29% | 9.33% | 22.15% | 23.06% |
December 31, 2024 calculation
Pretax margin = EBT ÷ Revenue
= $-305,300K ÷ $2,039,900K
= -14.97%
The pretax margin of Masimo Corporation has shown a decreasing trend over the years, declining from 23.06% on December 31, 2020, to -14.97% on December 31, 2024. This indicates a deterioration in the company's ability to generate profits before accounting for taxes. The significant drop in pretax margin from 2022 to 2024 suggests a potential decline in profitability and operational efficiency. It is crucial for Masimo Corporation to closely examine its cost structure and revenue streams to address the negative trend and improve its financial performance.
Peer comparison
Dec 31, 2024
Company name
Symbol
Pretax margin
Masimo Corporation
MASI
-14.97%
BioLife Solutions Inc
BLFS
-20.64%
CONMED Corporation
CNMD
6.49%
LivaNova PLC
LIVN
7.22%
Medtronic PLC
MDT
14.59%
TransMedics Group Inc
TMDX
-11.06%